Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before serovoncersion is associated with normalized immune parameters and limited viral reservoir

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before serovoncersion is associated with normalized immune parameters and limited viral reservoir. Journal of Infectious Diseases. 1999; 180:1827-32.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.